Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Quarterly results
CC transcript
Asset disposition
ARIAD PHARMACEUTICALS INC (ARIA) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/14/2011 BW ARIAD to Webcast Conference Call on Second Quarter 2011 Financial Results
07/05/2011 BW ARIAD Announces Presentation on Its Investigational Lung Cancer Drug Candidate, AP26113, a Dual Inhibitor of ALK and EGFR, at World Conference on Lung Cancer
06/01/2011 BW ARIAD to Present at the Jefferies 2011 Global Healthcare Conference
05/18/2011 BW ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2011 ASCO Annual Meeting
05/04/2011 BW ARIAD Reports First Quarter 2011 Financial Results and Development Progress
05/02/2011 BW ARIAD Names Norbert Riedel to Its Board of Directors
04/27/2011 BW ARIAD to Webcast Conference Call on First Quarter 2011 Financial Results
04/20/2011 BW ARIAD Announces Three Exclusive Out-License Agreements to Develop and Commercialize Its ARGENT™ Cell-Signaling Regulation Technology
04/05/2011 BW ARIAD Presents New Preclinical Data on Ponatinib in Solid Tumors, Demonstrating Inhibition of All FGF Receptor Kinases
03/31/2011 BW ARIAD to Present at the Leerink Swann Cancer Roundtable Conference
03/29/2011 BW ARIAD to Present New Preclinical Data on Ponatinib at the American Association for Cancer Research Annual Meeting
03/28/2011 BW ARIAD And MolecularMD Announce Collaboration for a Companion Diagnostic Test for The T315I BCR-ABL Mutation in Patients With CML
03/17/2011 BW ARIAD Announces Election to Co-Promote Ridaforolimus in Sarcoma Indication in U.S. upon Approval
03/08/2011 BW ARIAD to Present at the Barclays Capital 2011 Global Healthcare Conference
02/28/2011 BW ARIAD to Present at the 31st Annual Cowen Healthcare Conference
02/24/2011 BW ARIAD to Present at the 2011 RBC Capital Markets' Healthcare Conference
02/22/2011 BW ARIAD to Present at the CITI 2011 Global Healthcare Conference
02/17/2011 BW ARIAD Reports Development Progress and Fourth Quarter and Year-End 2010 Financial Results
02/10/2011 BW ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2010 Financial Results
12/06/2010 BW REPEAT/ ARIAD's Ponatinib Shows Clinical Evidence of Improving Anti-Leukemic Activity in Patients with Drug-Resistant CML
12/04/2010 BW ARIAD's Ponatinib Shows Clinical Evidence of Improving Anti-Leukemic Activity in Patients with Drug-Resistant CML
11/29/2010 BW Updated Clinical Data on ARIAD's Investigational pan-BCR-ABL Inhibitor, Ponatinib, to Be Presented at Annual American Society of Hematology Meeting
11/10/2010 BW ARIAD to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
11/09/2010 BW ARIAD Reports Third Quarter 2010 Financial Results and Development Progress
11/01/2010 BW ARIAD to Webcast Conference Call on Third Quarter 2010 Financial Results
10/26/2010 BW ARIAD Announces Pricing of Public Offering of Common Stock
10/25/2010 BW ARIAD Announces Proposed Public Offering of Common Stock
10/15/2010 BW Ariad to Present at the 17th Annual NewsMakers in the Biotech Industry Conference
09/28/2010 BW ARIAD to Present at the Jefferies Global SpecPharma and European Healthcare Conference
09/13/2010 BW ARIAD Announces Initiation of Ponatinib (AP24534) Pivotal Trial in Drug-Resistant or Intolerant Chronic Myeloid Leukemia
09/10/2010 BW ARIAD to Hold Conference Call on Monday, September 13, 2010 at 9:00 AM (ET)
09/08/2010 BW ARIAD to Present at the Rodman & Renshaw Annual Healthcare Conference
08/04/2010 BW ARIAD Reports Second Quarter 2010 Financial Results and Development Progress
07/21/2010 BW ARIAD to Webcast Conference Call on Second Quarter 2010 Financial Results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy